Understanding the HIV coreceptor switch from a dynamical perspective

BMC Evolutionary Biology

Volumn 9, Issue 1, 2009, Pages

  Kamp, Christel ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; VIRUS RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COMPUTER MODEL; CORECEPTOR SWITCHING; HUMAN IMMUNODEFICIENCY VIRUS; MOLECULAR EVOLUTION; NONHUMAN; PROBABILITY; RECEPTOR BINDING; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS STRAIN; BIOLOGICAL MODEL; EVOLUTION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MUTATION; VIROLOGY;

EVOLUTION; HIV INFECTIONS; HIV-1; HUMANS; MODELS, GENETIC; MUTATION; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECEPTORS, HIV;

EID: 72949091097     PISSN: None     EISSN: 14712148     Source Type: Journal    
DOI: 10.1186/1471-2148-9-274     Document Type: Article

References (42)

1. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. R Shankarappa JB Margolick SJ Gange AG Rodrigo D Upchurch H Farzadegan P Gupta CR Rinaldo GH Learn X He XL Huang JI Mullins, J Virol 1999 73 12 10489 10502 10559367
2. Unifying the epidemiological and evolutionary dynamics of pathogens. BT Grenfell OG Pybus JR Gog JL Wood JM Daly JA Mumford EC Holmes, Science 2004 303 5656 327 332 10.1126/science.1090727 14726583
3. Modeling within-host evolution of HIV: mutation, competition and strain replacement. CL Ball MA Gilchrist D Coombs, Bull Math Biol 2007 69 7 2361 2385 10.1007/s11538-007-9223-z 17554585
4. The HIV coreceptor switch: a population dynamical perspective. RR Regoes S Bonhoeffer, Trends Microbiol 2005 13 6 269 277 10.1016/j.tim.2005.04.005 15936659
5. Coreceptor switch in R5-tropic simian/human immunodeficiency virus-infected macaques. SH Ho S Tasca L Shek A Li A Gettie J Blanchard D Boden C Cheng-Mayer, J Virol 2007 81 16 8621 8633 10.1128/JVI.00759-07 17537860
6. Evolution of CCR5 Use Before and During Coreceptor Switching. M Coetzer R Nedellec J Salkowitz S McLaughlin Y Liu L Heath JI Mullins DE Mosier, J Virol 2008 82 23 11758 11766 10.1128/JVI.01141-08 18815295
7. R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simian-human immunodeficiency virus coreceptor switch. S Tasca SH Ho C Cheng-Mayer, J Virol 2008 82 14 7089 7099 10.1128/JVI.00570-08 18480460
8. No selection for CCR5 coreceptor usage during parenteral transmission of macrophagetropic syncytium-inducing human immunodeficiency virus type 1. FA Koning D Schols H Schuitemaker, J Virol 2001 75 18 8848 8853 10.1128/JVI.75.18.8848-8853.2001 11507230
9. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. AB van't Wout NA Kootstra GA Mulder-Kampinga N Albrecht-van Lent HJ Scherpbier J Veenstra K Boer RA Coutinho F Miedema H Schuitemaker, J Clin Invest 1994 94 5 2060 2067 10.1172/JCI117560 7962552
10. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. A Bjorndal H Deng M Jansson JR Fiore C Colognesi A Karlsson J Albert G Scarlatti DR Littman EM Fenyo, J Virol 1997 71 10 7478 7487 9311827
11. Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones. KK Arien Y Gali A El Abdellati L Heyndrickx W Janssens G Vanham, Virology 2006 347 65 74 10.1016/j.virol.2005.11.045 16386774
12. CXCR4-using Virus Detected in Patients Receiving Maraviroc in the Phase 3 Studies MOTIVATE 1 and 2 Originates form Pre-existing Minority of CXCR4-using Virus. M Lewis P Simpson S Fransen W Huang J Whitcomb M Mosley DL Dobertson R Mansfield G Ciaramella M Westby, Conference Reports for NATAP 2007 http://www.natap.org/2007/ResisWksp/ResisWksp-34.htm
13. The epidemiology of HIV coreceptor tropism. C Hoffmann, Eur J Med Res 2007 12 9 385 390 17933718
14. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. BF Keele EE Giorgi JF Salazar-Gonzalez JM Decker KT Pham MG Salazar C Sun T Grayson S Wang H Li X Wei C Jiang JL Kirchherr F Gao JA Anderson LH Ping R Swanstrom GD Tomaras WA Blattner PA Goepfert JM Kilby MS Saag EL Delwart MP Busch MS Cohen DC Montefiori BF Haynes B Gaschen GS Athreya HY Lee N Wood C Seoighe AS Perelson T Bhattacharya BT Korber BH Hahn GM Shaw, Proc Natl Acad Sci USA 2008 105 21 7552 7557 10.1073/pnas.0802203105 18490657
15. Naive and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy. RM Ribeiro MD Hazenberg AS Perelson MP Davenport, J Virol 2006 80 2 802 809 10.1128/JVI.80.2.802-809.2006 16378982
16. Modeling HIV quasispecies evolutionary dynamics. L Sguanci F Bagnoli P Lio, BMC Evol Biol 2007 7 Suppl 2 5 10.1186/1471-2148-7-S2-S5 17767733
17. Dynamics of macrophage and T cell infection by HIV. D Wodarz AL Lloyd VAA Jansen MA Nowak, Journal of Theoretical Biology 1999 196 101 113 10.1006/jtbi.1998.0816 9892559 (Pubitemid 29017553)
18. Virus phenotype switching and disease progression in HIV-1 infection. DS Callaway RM Ribeiro MA Nowak, Proceedings of the Royal Society of London Series B-Biological Sciences 1999 266 1437 2523 2530 10.1098/rspb.1999.0955
19. Acute or chronic?: Within-host models with immune dynamics, infection outcome, and parasite evolution. S Alizon M van Baalen, Am Nat 2008 172 6 244 E256 10.1086/592404 18999939
20. MA Nowak RM May, Virus Dynamics, Mathematical Principles of Immunology and Virology New York: Oxford University Press 2000
21. CCR5-Hemmer: Neuer Angriffspunkt bei HIV Infektion. S Heinzl, CTJ 2007 16 6 195 198 (Pubitemid 350290796)
22. Maraviroc for previously treated patients with R5 HIV-1 infection. RM Gulick J Lalezari J Goodrich N Clumeck E DeJesus A Horban J Nadler B Clotet A Karlsson M Wohlfeiler JB Montana M McHale J Sullivan C Ridgway S Felstead MW Dunne E van der Ryst H Mayer, New England Journal of Medicine 2008 359 14 1429 1U27 10.1056/NEJMoa0803152 18832244
23. Subgroup analyses of Maraviroc in previously treated R5 HIV-1 infection. G Fätkenheuer M Nelson A Lazzarin I Konourina AI Hoepelman H Lampiris B Hirschel P Tebas F Raffi B Trottier N Bellos M Saag DA Cooper M Westby M Tawadrous JF Sullivan C Ridgway MW Dunne S Felstead H Mayer RE van der, N Engl J Med 2008 359 14 1442 1455 10.1056/NEJMoa0803154 18832245
24. HIV coreceptor usage and drug treatment. R Regoes S Bonhoeffer, J Theor Biol 2002 217 4 443 457 10.1006/jtbi.2002.3049 12234752
25. Changes in HIV-1 tropism: Clinical and prognostic consequences. DE Mosier, European Journal of Medical Research 2007 12 9 371 374 17933716
26. The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease. MA Nowak RM May RM Anderson, AIDS 1990 4 11 1095 1103 10.1097/00002030-199011000-00007 2282182
27. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. SD Lawn ST Butera TM Folks, Clin Microbiol Rev 2001 14 4 753 77 10.1128/CMR.14.4.753-777.2001 11585784
28. Cell turnover and cell tropism in HIV-1 infection. MP Davenport JJ Zaunders MD Hazenberg H Schuitemaker RP van Rij, Trends Microbiol 2002 10 6 275 278 10.1016/S0966-842X(02)02370-3 12088663
29. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. AS Perelson AU Neumann M Markowitz JM Leonard DD Ho, Science 1996 271 5255 1582 1586 10.1126/science.271.5255.1582 8599114
30. Viral dynamics of acute HIV-1 infection. SJ Little AR McLean CA Spina DD Richman DV Havlir, J Exp Med 1999 190 6 841 850 10.1084/jem.190.6.841 10499922
31. Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient. EM Bunnik ED Quakkelaar AC van Nuenen B Boeser-Nunnink H Schuitemaker, J Virol 2007 81 2 525 531 10.1128/JVI.01983-06 17079299
32. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). MD Hazenberg JW Stuart SA Otto JC Borleffs CA Boucher RJ de Boer F Miedema D Hamann, Blood 2000 95 249 255 10607709
33. V3 loop sequence space analysis suggests different evolutionary patterns of CCR5- and CXCR4-tropic HIV. K Bozek A Thielen S Sierra R Kaiser T Lengauer, PLoS ONE 2009 4 10 7387 10.1371/journal.pone.0007387 19816596
34. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. B Chesebro K Wehrly J Nishio S Perryman, J Virol 1992 66 11 6547 6554 1404602
35. CW Gardiner, Handbook of Stochastic Methods for Physics, Chemistry and the Natural Sciences Springer 2008 3
36. G Latouche V Ramaswami, Introduction to Matrix Analytic Methods in Stochastic Modeling. ASA-SIAM 1999
37. Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution. RP van Rij MD Hazenberg BH van Benthem SA Otto M Prins F Miedema H Schuitemaker, AIDS Res Hum Retroviruses 2003 19 5 389 398 10.1089/088922203765551737 12803997
38. Phylodynamics of HIV-1 in lymphoid and non-lymphoid tissues reveals a central role for the thymus in emergence of CXCR4-using quasispecies. M Salemi BR Burkhardt RR Gray G Ghaffari JW Sleasman MM Goodenow, PLoS ONE 2007 2 9 950 10.1371/journal.pone.0000950 17895991
39. Reappearance of an 11-year-old sequence in an HIV-1 infected patient during treatment interruption. TV Madsen J Gerstoft C Nielsen LB Jorgensen, Scand J Infect Dis 2008 40 2 174 182 10.1080/00365540701558706 17926204
40. Emergence of CXCR4-using human immunodeficiency virus type 1(HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist Maraviroc is from a pretreatment CXCR4-using virus reservoir. M Westby M Lewis J Whitcomb M Youle AL Pozniak IT James TM Jenkins M Perros RE van der, J Virol 2006 80 10 4909 4920 10.1128/JVI.80.10.4909-4920.2006 16641282
41. A quasispecies approach to viral evolution in the context of an adaptive immune system. C Kamp, Microbes Infect 2003 5 15 1397 1405 10.1016/j.micinf. 2003.10.001 14670453
42. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. M Catalfamo M Di Mascio Z Hu S Srinivasula V Thaker J Adelsberger A Rupert M Baseler Y Tagaya G Roby C Rehm D Follmann HC Lane, Proc Natl Acad Sci USA 2008 105 50 19851 19856 10.1073/pnas.0810032105 19060209